Posted by on June 16, 2020 6:12 am
Tags:
Categories: Crispr Articles

Source: $20 million gift to establish a cancer immunotherapy laboratory – News – The University of Sydney

A $20 million gift to the University of Sydney from the CLEARbridge Foundation will fund a new Professorial Chair, a laboratory, and vital supporting resources to drive immunotherapy research. Widely considered the most promising emerging treatment, immunotherapy offers exciting new ways to combat a broad range of cancers.

Professor Robyn Ward, Dean of the Faculty of Medicine and Health at the University said:

“The global research community has made extraordinary advances in developing immunotherapies for cancers over the last 10 years. The development of these highly effective treatments occurred because of fundamental research which dates back to the 1890s.

“This funding brings us closer to a day when researchers will fully understand the immune system, and can use that knowledge to maximum effect, not only against cancer, but other immune- related diseases like rheumatoid arthritis and multiple sclerosis.”

Dr Michael Spence, Vice-Chancellor and Principal said:

“When you consider that cancer continues to be the second leading cause of death globally, with Australia having one of the highest melanoma rates in the world, you appreciate the potential impact of this incredible gift.

“We are so grateful for this opportunity to broaden and deepen the University’s research capability. Together with our teaching hospitals and affiliated research institutions we could advance medical treatment in ways we cannot quite yet imagine.”

Published at Mon, 15 Jun 2020 23:03:00 +0000